Tower Research Capital LLC (TRC) - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 40 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$31
-29.5%
268,781
+4.0%
0.00%
-50.0%
Q4 2022$44
-99.9%
258,409
+52.0%
0.00%
+100.0%
Q3 2022$34,000
-60.5%
170,011
-1.1%
0.00%
-50.0%
Q2 2022$86,000
-9.5%
171,928
+3.0%
0.00%
+100.0%
Q1 2022$95,000
+196.9%
167,000
+208.5%
0.00%0.0%
Q4 2021$32,000
-34.7%
54,132
+6.4%
0.00%0.0%
Q3 2021$49,000
+69.0%
50,872
+89.8%
0.00%0.0%
Q2 2021$29,000
+222.2%
26,796
+195.8%
0.00%
Q1 2021$9,000
+50.0%
9,060
-23.2%
0.00%
Q4 2020$6,000
-68.4%
11,793
-67.0%
0.00%
-100.0%
Q2 2020$19,000
+1800.0%
35,755
+3859.6%
0.00%
Q2 2019$1,0009030.00%
Q1 2017$0
-100.0%
0
-100.0%
0.00%
Q3 2016$3,000
+50.0%
993
+273.3%
0.00%
Q1 2016$2,000
-71.4%
266
-86.2%
0.00%
-100.0%
Q3 2015$7,000
+250.0%
1,926
+423.4%
0.00%
Q2 2015$2,000368
+418.3%
0.00%
Q2 2014$0710.00%
Q1 2014$0
-100.0%
0
-100.0%
0.00%
Q4 2013$1,0002180.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders